Mauro Maniscalco
Overview
Explore the profile of Mauro Maniscalco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
1378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcuccio G, Candia C, Maniscalco M, Ambrosino P
Front Med (Lausanne)
. 2025 Mar;
12:1550716.
PMID: 40046916
Chronic obstructive pulmonary disease (COPD) is a complex condition marked by chronic respiratory symptoms, such as cough and dyspnoea, and persistent irreversible airway obstruction, punctuated by acute episodes of exacerbations....
2.
Marcuccio G, Raffio G, Ambrosino P, Candia C, Cantone E, Detoraki A, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941555
Nasal cytology is a non-invasive, affordable, and easily executable technique commonly used in research to study rhinitis and, to a lesser extent, chronic rhinosinusitis. It is particularly useful for the...
3.
Sposato B, Scalese M, Camiciottoli G, Carpagnano G, Pelaia C, Santus P, et al.
J Asthma
. 2025 Jan;
1-6.
PMID: 39783623
Objective: It remains unclear whether baseline FeNO levels can predict response to anti-IL5/5R biologic treatment in patients with severe asthma. Methods: We recruited 104 patients with severe eosinophilic asthma treated...
4.
Ambrosino P, Nolano M, Candia C, Grassi G, Maniscalco M
Antioxidants (Basel)
. 2025 Jan;
13(12.
PMID: 39765871
Chronic respiratory diseases (CRDs) are highly prevalent conditions, causing over 4 million deaths every year and representing a major source of physical, psychological, and occupational disability [...].
5.
Moretta P, Cavallo N, Candia C, Lanzillo A, Marcuccio G, Santangelo G, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518558
Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease characterized by chronic airflow limitation and persistent respiratory symptoms. It is a major cause of morbidity and mortality worldwide, significantly...
6.
Maniscalco M, Candia C, Ambrosino P, Iovine A, Fuschillo S
Eur J Intern Med
. 2024 Oct;
131:27-35.
PMID: 39443246
COPD is a chronic, heterogeneous inflammatory disorder of the airways with persistent and poorly reversible airflow limitation, causing symptoms such as cough, shortness of breath, and sputum production. Despite optimal...
7.
Ambrosino P, Vitacca M, Marcuccio G, Spanevello A, Ambrosino N, Maniscalco M
Chest
. 2024 Oct;
167(2):387-401.
PMID: 39427705
Background: Alongside the recognized Global Initiative for Obstructive Lung Disease (GOLD) classification, the Staging of Airflow Obstruction by Ratio (STAR) severity scheme has been proposed for categorizing COPD. Study Question:...
8.
Ambrosino P, Candia C, Merola C, Lombardi C, Mancusi C, Matera M, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407809
: Chronic obstructive pulmonary disease (COPD) is associated with subclinical atherosclerosis and endothelial dysfunction, which can be assessed non-invasively through flow-mediated dilation (FMD). In this study, we evaluated the potential...
9.
Maniscalco M, Candia C, Visca D, DAmato M, Calabrese C, Ambrosino P, et al.
ERJ Open Res
. 2024 Sep;
10(5).
PMID: 39319043
https://bit.ly/3xWszYJ.
10.
Maniscalco M, Calzetta L, Rogliani P, Cazzola M
Expert Rev Clin Pharmacol
. 2024 Sep;
:1-9.
PMID: 39313486
Introduction: COPD is a leading cause of global mortality, particularly under-recognized and under-diagnosed. In 2020, it was the sixth leading cause of death in the US and has contributed to...